BIO-TECHNE CORP's ticker is TECH and the CUSIP is 09073M104. A total of 431 filers reported holding BIO-TECHNE CORP in Q4 2020. The put-call ratio across all filers is 1.11 and the average weighting 0.2%.
About BIO-TECHNE CORP
Bio-Techne Corp is a leading provider of innovative life science research tools and diagnostic solutions. The company is headquartered in Minneapolis, Minnesota, and has operations in over 50 countries worldwide. Bio-Techne's products and services are used by researchers and clinicians in a wide range of fields, including cancer research, stem cell research, and immunology.
Bio-Techne's success is due in large part to its commitment to innovation and customer service. The company invests heavily in research and development, and has a team of over 1,000 scientists working to develop new products and technologies. Bio-Techne also has a strong focus on customer service, with a dedicated team of technical support specialists available to assist customers with any questions or issues they may have.
In addition to its research tools and diagnostic solutions, Bio-Techne also has a growing portfolio of clinical diagnostic products. The company's Exosome Diagnostics subsidiary is a leader in the development of liquid biopsy tests for cancer diagnosis and monitoring.
Bio-Techne's leadership team is comprised of experienced executives with a track record of success in the life sciences industry. Charles Kummeth, the company's CEO, has been with Bio-Techne since 2013 and has overseen significant growth and expansion during his tenure.
Overall, Bio-Techne is a company with a strong reputation for innovation, customer service, and leadership in the life sciences industry. With a growing portfolio of products and services, the company is well-positioned for continued success in the years to come.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $3,063,899 | -18.5% | 45,011 | -2.2% | 0.02% | -14.3% |
Q2 2023 | $3,757,347 | +8.3% | 46,029 | -1.6% | 0.03% | +7.7% |
Q1 2023 | $3,468,754 | -11.2% | 46,755 | -0.8% | 0.03% | -16.1% |
Q4 2022 | $3,907,958 | +14.5% | 47,152 | +292.2% | 0.03% | +6.9% |
Q3 2022 | $3,413,964 | -19.0% | 12,021 | -1.1% | 0.03% | -14.7% |
Q2 2022 | $4,213,409 | -21.7% | 12,155 | -2.2% | 0.03% | -5.6% |
Q1 2022 | $5,384,419 | +19.9% | 12,434 | +43.2% | 0.04% | -5.3% |
Q4 2021 | $4,492,063 | +5.5% | 8,683 | -1.1% | 0.04% | -2.6% |
Q3 2021 | $4,256,463 | -51.4% | 8,784 | -54.8% | 0.04% | -53.0% |
Q2 2021 | $8,750,353 | +14.3% | 19,434 | -3.0% | 0.08% | +13.7% |
Q1 2021 | $7,654,641 | +14.1% | 20,042 | -5.1% | 0.07% | +7.4% |
Q4 2020 | $6,709,196 | +22.7% | 21,128 | -4.3% | 0.07% | +13.3% |
Q3 2020 | $5,467,897 | -8.8% | 22,072 | -2.8% | 0.06% | -11.8% |
Q2 2020 | $5,994,125 | +44.5% | 22,699 | +3.8% | 0.07% | +17.2% |
Q1 2020 | $4,148,317 | -13.6% | 21,877 | 0.0% | 0.06% | +16.0% |
Q4 2019 | $4,802,220 | +10.9% | 21,877 | -1.2% | 0.05% | +2.0% |
Q3 2019 | $4,331,938 | -7.4% | 22,139 | -1.3% | 0.05% | -5.8% |
Q2 2019 | $4,678,307 | +2.4% | 22,439 | -2.5% | 0.05% | 0.0% |
Q1 2019 | $4,570,820 | +37.2% | 23,021 | -0.0% | 0.05% | +23.8% |
Q4 2018 | $3,332,612 | -29.3% | 23,028 | -0.3% | 0.04% | -16.0% |
Q3 2018 | $4,714,941 | +34.9% | 23,100 | -2.2% | 0.05% | +22.0% |
Q2 2018 | $3,494,000 | -1.1% | 23,615 | +1.0% | 0.04% | -2.4% |
Q1 2018 | $3,532,000 | +15.0% | 23,386 | -1.3% | 0.04% | +20.0% |
Q4 2017 | $3,071,000 | – | 23,703 | – | 0.04% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Broadcrest Asset Management, LLC | 300,000 | $24,489,000 | 21.05% |
Montanaro Asset Management Ltd | 388,800 | $31,737,744 | 5.02% |
Sandhill Capital Partners LLC | 502,447 | $41,014,775 | 3.74% |
Brown Capital Management | 3,160,892 | $258,023,614 | 3.66% |
DF DENT & CO INC | 3,275,617 | $267,388,640 | 3.62% |
Ownership Capital B.V. | 2,282,104 | $186,288,150 | 3.26% |
Jackson Square Partners, LLC | 1,361,789 | $111,162,836 | 3.24% |
STONE RUN CAPITAL, LLC | 88,135 | $7,194,460 | 3.20% |
Pembroke Management, LTD | 339,591 | $27,720,813 | 2.99% |
Summit Creek Advisors LLC | 283,693 | $23,157,860 | 2.90% |